Fast Facts


Group Health Research Institute does practical research to keep people healthy.

Group Health Research Institute (GHRI) is the research arm of Group Health Cooperative, a Seattle-based, consumer-governed, nonprofit health care system that coordinates health care and coverage for more than 600,000 people.


Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems.

Faculty and staff

About 60 health scientists—including physicians, epidemiologists, biostatisticians, psychologists, economists, and health services researchers. Most faculty members have a joint appointment at the University of Washington. GHRI also employs about 300 other staff members.


In 2013, GHRI’s external revenue exceeded $47 million.

  • Federal agencies (NIH, CDC, AHRQ, etc.) = 77% of GHRI's annual budget.
  • Grants and contracts from foundations and industry (Robert Wood Johnson, Amgen, Johnson & Johnson, Pfizer, GlaxoSmithKline, etc.) = 13%.
  • Group Health = 5%.
  • Other (includes industry) = 5%.


GHRI belongs to several national consortia, including the HMO Research Network, which has data on about 12 million lives. Others include the Cancer Research Network, and the Breast Cancer Surveillance Consortium. GHRI also hosts one of eight federally funded Vaccine and Treatment Evaluation Units.

Our centers

The MacColl Center for Health Care Innovation and the Center for Community Health and Evaluation are part of GHRI.


GHRI shares its findings primarily through articles in peer-reviewed medical journals, presentations at scientific meetings, and the media.


In 2013, GHRI managed a total of 292 active grants and published 353 articles in peer-reviewed medical journals.